Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 828
Guide Official Revision Description Reason for Update
Version Date Number Of Change
Revised CGM Renewal
Requirements page.
2023 08/30/2023 20. Medical Policy In Disease Protocols,
Diabetes Mellitus Type I or
Type II - Insulin Treated
CGM Option, added new
color view and samples to
CGM Data Report Examples.
2023 08/30/2023 21. Medical Policy In Disease Protocols,
Diabetes Mellitus Type I or
Type II - Insulin Treated
CGM Option, revised and
added information to
Frequently Asked Questions
(FAQs).
2023 08/30/2023 22. Administrative In Protocol for Insulin-
Treated Diabetes Mellitus
Non-CGM - Third-Class
Option, added cover page
and index.
2023 07/26/2023 1. Medical Policy In Pharmaceuticals,
Diabetes Mellitus – Type II
Medication Controlled (Not
Insulin), revised the
Acceptable Combination of
Diabetes Medications.
Changed SGLT2 inhibitors
(Group F) initial observation
time to 30 days; added
information for when
switching dosing or
formulations within the same
drug class or device
manufacturer; added new
GIP/GLP drug class under
Group C; and removed
restriction of Group F used
with Group E.
2023 07/26/2023 2. Medical Policy In Item 36. Heart, revised
Atrial Fibrillation Disposition
Table to specify that ≥ 24-
hour cardiac monitor must
be current.
2023 07/26/2023 3. Medical Policy In Disease Protocols,
Medication Controlled
Metabolic Syndrome
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
